Haloette 11.7 mg (Etonogestrel RING (SLOW-RELEASE)) 11.7 MG

HALOETTE 11.7 MG is a vaginal ring containing etonogestrel, a progestin hormone. It is used for contraception and may help regulate menstrual cycles. This slow-release ring is designed for convenient, long-term use.

Strength

11.7 MG

Manufacturer / TM Owner

SEARCHLIGHT PHARMA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HALOETTE 11.7 MG is primarily used for contraception. The etonogestrel ring is inserted into the vagina, where it slowly releases the hormone to prevent ovulation. This method is often chosen for its convenience and effectiveness in birth control. Many users also find it helpful in managing menstrual irregularities.

Side Effects

Common effects of using HALOETTE 11.7 MG may include changes in menstrual bleeding patterns, such as lighter or more frequent periods. Some users experience headaches, breast tenderness, or mood changes. These effects vary and typically subside as the body adjusts to the hormone.

Precautions & Warnings

HALOETTE 11.7 MG should be handled with clean hands to avoid infection. It is important to follow the insertion and removal instructions provided by a healthcare professional. Regular check-ups are recommended to monitor any potential side effects or changes in health.

Avoid Interactions

HALOETHE 11.7 MG may interact with certain medications, including those that affect liver enzymes. It is advisable to consult a healthcare provider before using this ring if you are taking other medications, especially antibiotics or anticonvulsants. Alcohol does not typically interact with this contraceptive method.

Frequently Asked Questions

HALOETTE 11.7 MG is used for contraception and may help regulate menstrual cycles.

The etonogestrel ring releases a progestin hormone slowly into the body to prevent ovulation, providing contraceptive effects.

Common side effects may include changes in menstrual bleeding, headaches, breast tenderness, and mood changes.

The HALOETTE 11.7 MG ring is typically designed for long-term use, but the exact duration should be confirmed with a healthcare provider.

It is advisable to consult a healthcare provider before using HALOETTE 11.7 MG if you are taking other medications, especially antibiotics or anticonvulsants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.